Close Menu

NEW YORK ─ The US Food and Drug Administration on Tuesday revoked its Emergency Use Authorization of Chembio Diagnostic's DPP COVID-19 IgM/IgG test because of concerns about its sensitivity and specificity.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.